IMAX shares jumped roughly 14 percent Friday after reports surfaced that the premium-screen company is exploring a sale, and analysts rushed to name who might write the check.
A source familiar with the company told CNBC that IMAX has held preliminary talks through intermediaries, though no official pitches have been made by the company. The Wall Street Journal first reported the potential sale process.
By midday Friday, IMAX shares were trading near $39 apiece, giving the company a market capitalization of roughly $2.1 billion. That figure sits well below the 52-week high of $43.16 a share the stock hit in late February, and far below what several equity analysts say the brand is actually worth.
The numbers tell a straightforward story. Last year, IMAX generated a record $1.28 billion at the global box office, more than 40 percent above 2024 and 13 percent higher than its previous record, set in 2019. Revenue in 2019 was $396 million, with adjusted profit of $149 million. Texas Capital Securities executive director of equity research Eric Wold projects 2026 revenue of $448 million and adjusted profit of $197 million.
By those measures, IMAX is outperforming its pre-pandemic self. Its valuation has not caught up.
Wedbush Senior Vice President of Equity Research Alicia Reese put it bluntly in a Friday research note:
"IMAX is trading at a discount to what we believe the business is worth as a standalone entity, let alone as a strategic acquisition target."
Reese described IMAX as "a rare combination of a globally recognized premium brand, an asset-light licensing model, and a structurally expanding earnings profile." She added that a buyer would be picking up "one of the most defensible moats in entertainment for what amounts to a rounding error on the balance sheet of any major studio or technology platform."
That kind of language from a sell-side analyst is not subtle. It reads like a for-sale sign planted on the front lawn.
The list of plausible suitors is unusually long for a company this size, and the reason is structural. IMAX does not own theaters. It licenses its technology and brand to exhibitors worldwide. That asset-light model makes it look less like a movie-theater chain and more like a premium technology platform, which broadens the buyer pool considerably.
Benchmark equity research analyst Mike Hickey framed it this way in a Friday note:
"We believe the potential buyer universe is unusually broad because IMAX operates less like a traditional theater chain and more like a premium entertainment technology platform."
Hickey listed Sony, Apple, Amazon, Disney, Comcast/NBCUniversal, Netflix, Sphere Entertainment, and Cinépolis as logical strategic candidates, alongside sovereign-backed entertainment investors.
Reese narrowed the field. She suggested the most likely suitors would include private equity, Netflix, Apple, and Sony. Private equity, she noted, would avoid potential conflict issues because there would be no competing interest for screens. Netflix's conflict of interest would be smaller than that of traditional Hollywood studios because Netflix does not rely on theatrical releases as its main programming strategy. Owning IMAX, Reese wrote, could give filmmakers working with Netflix the chance for premium theatrical runs and could serve as a "powerful recruiting tool."
Sony and Apple, she noted, both have strong technology businesses in addition to content arms. Sony lacks its own streaming platform, while Apple has AppleTV.
Not everyone on Wall Street sees a clean path for the big Hollywood names. Wold, in a note published Thursday, said he would be surprised if any major studio pursued IMAX. His reasoning was practical, not speculative:
"We would be surprised if any of the major Hollywood studios pursued an acquisition of IMAX given the competition with other studios for key IMAX release windows (and the likelihood that a studio would not want to share box office with another studio)."
Wold extended the same logic to major theater circuits:
"By the same token, we do not believe any of the major exhibitor circuits would want another circuit to control the IMAX release slate and also share in its box office revenues."
The competitive dynamics are real. If Disney bought IMAX, would Universal or Warner Bros. keep sending their biggest films to IMAX screens? The question answers itself. That structural tension is why private equity and tech companies may have the cleanest shot.
Whatever happens on the deal front, IMAX's near-term slate is formidable. Universal and Christopher Nolan's "The Odyssey" is due in July. Warner Bros. and Denis Villeneuve's "Dune: Part Three" arrives in December. Both films are expected to generate a significant portion of box office sales from IMAX screenings.
IMAX did lose Greta Gerwig's "Narnia" from the Thanksgiving holiday window after an on-set injury postponed production. The company replaced it with David Fincher's "The Adventures of Cliff Booth," based on the breakout character from Quentin Tarantino's "Once Upon a Time in Hollywood."
Rosenblatt senior research analyst Steve Frankel outlined the longer view in a Friday note. He wrote that IMAX has at least 10 filmed-for-IMAX titles in 2027, including "Narnia," Star Wars, Superman, Batman, "The Thomas Crown Affair," and "Miami Vice." Previous filmed-for-IMAX titles include James Cameron's and Disney's Avatar films. Disney's "Toy Story 5" and "Moana," Universal's "Minions & Monsters," Warner Bros.' "Supergirl," and Lionsgate's "Hunger Games: Sunrise on the Reaping" are also on the upcoming slate.
Frankel noted that IMAX's content pipeline extends well beyond Hollywood tentpoles:
"Beyond Hollywood, the company's slate of local language titles continues to expand, including multiple titles Filmed for IMAX and alternative content, like live broadcasts of F1 races, continues to fill in gaps in the schedule."
IMAX has reduced its dependence on any single market or content source by partnering internationally with China, Japan, and South Korea to screen local-language content. The Chinese animated film "Ne Zha 2" had a record-breaking performance on IMAX screens earlier this year.
The company is not standing still on installations, either. IMAX told CNBC last year that it expects to install around 160 to 175 systems in 2026, with contracts to build hundreds more already in place. Its filmed-for-IMAX content is expected to grow materially through 2028.
Frankel summed up his outlook plainly:
"The combination of the ongoing consumer shift to premium viewing experiences, the company's growing influence with leading filmmakers and a film slate that has diversified beyond Hollywood tent poles to include local languages and alternative content, sets the stage for strong box office growth and margin expansion."
Wold reiterated his price target of $53 a share, well above Friday's trading level near $39.
IMAX CEO Rich Gelfond may have tipped his hand months ago. In December, he told shareholders during the company's investor day that IMAX is "an incredibly valuable player, either as a wholly differentiated publicly-traded company or as part of a larger company."
That phrasing, "or as part of a larger company", is not the kind of line a CEO drops by accident at an investor day. It signals openness. Whether it signals urgency is another question entirely.
Much remains unclear. No one has disclosed which entities, if any, participated in the preliminary intermediary talks. No terms or valuation levels have surfaced publicly. IMAX has not provided an on-the-record response to the sale speculation.
The 14 percent single-day pop in IMAX shares tells you the market believes a deal is plausible, and that the current price undervalues the company. Analysts across multiple firms are saying the same thing in different ways: IMAX is a premium brand with an asset-light model, a growing global footprint, a diversifying content pipeline, and a valuation that has not recovered from pandemic-era discounting.
For free-market conservatives, the IMAX situation is a clean case study. Here is a company that built a globally recognized brand, expanded internationally, kept its balance sheet lean, and posted record results, and the market still hasn't priced it right. If a buyer steps up and pays a fair premium, shareholders win. If IMAX stays independent and keeps executing, shareholders should win anyway.
The real question is whether any of the tech giants or private equity firms on the suitor list can resist a brand this strong at a price this modest. A $2.1 billion market cap is, as Reese put it, a rounding error for any major studio or technology platform.
In a media landscape where every streaming service is chasing subscribers and every studio is chasing spectacle, the company that owns the biggest screen in the room ought to be worth more than a rounding error.